News

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design and ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...
eWeek18d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Thrive Capital led the financing round with participation from Google’s GV, and follow-on capital from Alphabet, its parent company and an existing investor. Isomorphic Labs described plans to ...
NBC Los Angeles12d
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind
The fledgling company was Isomorphic Labs, the secretive artificial intelligence ... While Isomorphic is an independent unit of Google parent Alphabet, Hassabis' dual roles reflect the intertwined ...